Log in
Enquire now
‌

US Patent 11254651 Histone methyltransferase inhibitors

Patent 11254651 was granted and assigned to Global Blood Therapeutics on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 11254651 Histone methyltransferase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.